Publications

Celebrating the research activities and achievements of our sponsored Investigator-Initiated Trials

BelaCarD FOR RELAPSED REFRACTORY MULTIPLE MYELOMA (PHASE I/II)

AMaRC 19-02

VCD-D FOR TRANSPLANT INELIGIBLE MYELOMA (PHASE II)

AMaRC 03-16

KAPPAMAB FOR RELAPSED REFRACTORY MULTIPLE MYELOMA (PHASE IIB)

AMaRC 16-01

ITD FOR RELAPSED REFRACTORY MULTIPLE MYELOMA (PHASE II)

AMaRC 16-02